Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study.

Katanga J, Kjaer SK, Manongi R, Wu CS, Iftner T, Waldstrom M, Pembe AB, Mwaiselage J, Rasch V.

PLoS One. 2019 Jun 19;14(6):e0218559. doi: 10.1371/journal.pone.0218559. eCollection 2019.

2.

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M.

Geburtshilfe Frauenheilkd. 2019 Feb;79(2):160-176. doi: 10.1055/a-0828-7722. Epub 2019 Feb 18.

3.

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M.

Geburtshilfe Frauenheilkd. 2019 Feb;79(2):148-159. doi: 10.1055/a-0818-5440. Epub 2019 Feb 18.

4.

Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study.

Serna-Higuita LM, Harrison SL, Buttner P, Glasby M, Raasch BA, Iftner A, Garbe C, Martus P, Iftner T.

Acta Derm Venereol. 2019 Apr 1;99(4):404-411. doi: 10.2340/00015555-3107.

5.

Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.

Baldur-Felskov B, Mwaiselage J, Faber MT, Kjaerem M, de la Cour CD, Munk C, Kahesa C, Iftner T, Rasch V, Kjaer SK.

Trop Med Int Health. 2019 Feb;24(2):229-237. doi: 10.1111/tmi.13184. Epub 2018 Dec 2.

PMID:
30444556
6.

Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.

Rataj O, Haedicke-Jarboui J, Stubenrauch F, Iftner T.

Int J Cancer. 2019 May 1;144(9):2330-2338. doi: 10.1002/ijc.31986. Epub 2019 Jan 16.

PMID:
30421459
7.

Refolding and in vitro characterization of human papillomavirus 16 minor capsid protein L2.

Breiner B, Preuss L, Roos N, Conrady M, Lilie H, Iftner T, Simon C.

Biol Chem. 2019 Mar 26;400(4):513-522. doi: 10.1515/hsz-2018-0311.

PMID:
30375341
8.

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany.

Iftner T, Neis KJ, Castanon A, Landy R, Holz B, Woll-Herrmann A, Iftner A, Staebler A, Wallwiener D, Hann von Weyhern C, Neis F, Haedicke-Jarboui J, Martus P, Brucker S, Henes M, Sasieni P.

J Clin Microbiol. 2019 Jan 2;57(1). pii: e01177-18. doi: 10.1128/JCM.01177-18. Print 2019 Jan.

9.

Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.

Sand FL, Munk C, Frederiksen K, Junge J, Iftner T, Dehlendorff C, Kjaer SK.

Int J Cancer. 2019 Apr 15;144(8):1975-1982. doi: 10.1002/ijc.31883. Epub 2019 Jan 10.

PMID:
30246864
10.

Cottontail Rabbit Papillomavirus E1 and E2 Proteins Mutually Influence Their Subcellular Localizations.

Schneider M, Yigitliler A, Stubenrauch F, Iftner T.

J Virol. 2018 Oct 12;92(21). pii: e00704-18. doi: 10.1128/JVI.00704-18. Print 2018 Nov 1.

11.

HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis.

Mauz PS, Schäfer FA, Iftner T, Gonser P.

BMC Infect Dis. 2018 Jul 24;18(1):343. doi: 10.1186/s12879-018-3260-0.

12.

Vaginal prevalence of human papillomavirus infections in women with uterovaginal aplasia before and after laparoscopically assisted creation of a neovagina: a prospective epidemiological observational study.

Rall KK, Schoenfisch B, Schoeller D, Stefanescu D, Koelle A, Henes M, Huebner M, Taran FA, Seeger H, Iftner A, Iftner T, Brucker SY.

BJOG. 2019 Jan;126(1):65-72. doi: 10.1111/1471-0528.15404. Epub 2018 Aug 20.

PMID:
29992731
13.

HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Manawapat-Klopfer A, Wang L, Haedicke-Jarboui J, Stubenrauch F, Munk C, Thomsen LT, Martus P, Kjaer SK, Iftner T.

Am J Cancer Res. 2018 Apr 1;8(4):715-722. eCollection 2018.

14.

The contribution of SP100 to cottontail rabbit papillomavirus transcription and replication.

Wurdak M, Schneider M, Iftner T, Stubenrauch F.

J Gen Virol. 2018 Jan 24. doi: 10.1099/jgv.0.001012. [Epub ahead of print]

PMID:
29458675
15.

Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers.

Petry KU, Liebrich C, Luyten A, Zander M, Iftner T.

Papillomavirus Res. 2017 Dec;4:85-89. doi: 10.1016/j.pvr.2017.10.003. Epub 2017 Oct 19.

16.

Identification and Functional Characterization of Phosphorylation Sites of the Human Papillomavirus 31 E8^E2 Protein.

van de Poel S, Dreer M, Velic A, Macek B, Baskaran P, Iftner T, Stubenrauch F.

J Virol. 2018 Jan 30;92(4). pii: e01743-17. doi: 10.1128/JVI.01743-17. Print 2018 Feb 15.

17.

Sexual inactivity and occurrence of STIs in relation to weight status in women: Two large population-based studies.

Gunge VB, Juul KE, van den Brule AJC, Iftner T, Kjær SK.

Women Health. 2018 Aug;58(7):790-805. doi: 10.1080/03630242.2017.1353572. Epub 2017 Aug 25.

PMID:
28742991
18.

Involvement of Brd4 in different steps of the papillomavirus life cycle.

Iftner T, Haedicke-Jarboui J, Wu SY, Chiang CM.

Virus Res. 2017 Mar 2;231:76-82. doi: 10.1016/j.virusres.2016.12.006. Epub 2016 Dec 10. Review.

19.

Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.

Iftner T, Wang L, Iftner A, Holz B, Haedicke-Jarboui J, Iftner N, von Wasielewski R, Martus P, Boehmer G.

BMC Infect Dis. 2016 Nov 11;16(1):672.

20.

TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.

Manawapat-Klopfer A, Thomsen LT, Martus P, Munk C, Russ R, Gmuender H, Frederiksen K, Haedicke-Jarboui J, Stubenrauch F, Kjaer SK, Iftner T.

Am J Cancer Res. 2016 Jul 1;6(7):1524-36. eCollection 2016.

21.

Risk factors for genital human papillomavirus among men in Tanzania.

Olesen TB, Mwaiselage J, Iftner T, Kahesa C, Rasch V, Frederiksen K, Munk C, Kjaer SK.

J Med Virol. 2017 Feb;89(2):345-351. doi: 10.1002/jmv.24627. Epub 2016 Jul 20.

PMID:
27404999
22.

Risk factors for HIV positivity among more than 3,400 Tanzanian women.

Faber MT, Munk C, Mwaiselage J, Dartell M, Kahesa C, Iftner T, Rasch V, Kjaer SK.

Women Health. 2017 Jul;57(6):650-664. doi: 10.1080/03630242.2016.1202882. Epub 2016 Jul 5.

PMID:
27379612
23.

Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication.

Dreer M, Fertey J, van de Poel S, Straub E, Madlung J, Macek B, Iftner T, Stubenrauch F.

PLoS Pathog. 2016 Apr 11;12(4):e1005556. doi: 10.1371/journal.ppat.1005556. eCollection 2016 Apr.

24.

Risk Factors for Incident and Redetected Chlamydia trachomatis Infection in Women: Results of a Population-Based Cohort Study.

Harder E, Thomsen LT, Frederiksen K, Munk C, Iftner T, van den Brule A, Kjaer SK.

Sex Transm Dis. 2016 Feb;43(2):113-9. doi: 10.1097/OLQ.0000000000000394.

PMID:
26760181
25.

Papillomavirus-Associated Tumor Formation Critically Depends on c-Fos Expression Induced by Viral Protein E2 and Bromodomain Protein Brd4.

Delcuratolo M, Fertey J, Schneider M, Schuetz J, Leiprecht N, Hudjetz B, Brodbeck S, Corall S, Dreer M, Schwab RM, Grimm M, Wu SY, Stubenrauch F, Chiang CM, Iftner T.

PLoS Pathog. 2016 Jan 4;12(1):e1005366. doi: 10.1371/journal.ppat.1005366. eCollection 2016 Jan.

26.

A review of the clinical performance of the Aptima HPV assay.

Haedicke J, Iftner T.

J Clin Virol. 2016 Mar;76 Suppl 1:S40-S48. doi: 10.1016/j.jcv.2015.10.027. Epub 2015 Nov 6. Review.

27.

Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.

Habiger C, Jäger G, Walter M, Iftner T, Stubenrauch F.

J Virol. 2015 Oct 21;90(2):694-704. doi: 10.1128/JVI.02137-15. Print 2016 Jan 15.

28.

RNA sequencing analysis identifies novel spliced transcripts but does not indicate quantitative or qualitative changes of viral transcripts during progression of cottontail rabbit papillomavirus-induced tumours.

Probst-Hunczek S, Jäger G, Schneider M, Notz E, Stubenrauch F, Iftner T.

J Gen Virol. 2015 Oct;96(10):3083-9. doi: 10.1099/jgv.0.000239. Epub 2015 Jul 9.

PMID:
26297146
29.

Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study.

Stensen S, Kjaer SK, Jensen SM, Frederiksen K, Junge J, Iftner T, Munk C.

Int J Cancer. 2016 Jan 15;138(2):361-8. doi: 10.1002/ijc.29719. Epub 2015 Aug 13.

30.

Human Papillomavirus Infection Among 2460 Men in Denmark: Prevalence in Relation to Age Using 2 Human Papillomavirus DNA Testing Methods.

Hebnes JB, Munk C, Nøhr B, Nielsen A, Jørgensen HO, Iftner T, Kjaer SK.

Sex Transm Dis. 2015 Aug;42(8):463-7. doi: 10.1097/OLQ.0000000000000315.

PMID:
26165439
31.

Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization.

Gosvig CF, Huusom LD, Andersen KK, Duun-Henriksen AK, Frederiksen K, Iftner A, Svare E, Iftner T, Kjaer SK.

Int J Cancer. 2015 Dec 15;137(12):2927-33. doi: 10.1002/ijc.29673. Epub 2015 Jul 25.

32.

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.

Iftner T, Becker S, Neis KJ, Castanon A, Iftner A, Holz B, Staebler A, Henes M, Rall K, Haedicke J, von Weyhern CH, Clad A, Brucker S, Sasieni P.

J Clin Microbiol. 2015 Aug;53(8):2509-16. doi: 10.1128/JCM.01013-15. Epub 2015 May 27.

33.

Characterization of the Human Papillomavirus 16 E8 Promoter.

Straub E, Fertey J, Dreer M, Iftner T, Stubenrauch F.

J Virol. 2015 Jul;89(14):7304-13. doi: 10.1128/JVI.00616-15. Epub 2015 May 6.

34.

Role of human papillomavirus testing and cytology in follow-up after conization.

Gosvig CF, Huusom LD, Deltour I, Andersen KK, Duun-Henriksen AK, Madsen EM, Petersen LK, Elving L, Schouenbourg L, Iftner A, Svare E, Iftner T, Kjaer SK.

Acta Obstet Gynecol Scand. 2015 Apr;94(4):405-11. doi: 10.1111/aogs.12601. Epub 2015 Feb 27.

PMID:
25645089
35.

A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.

Boehmer G, Wang L, Iftner A, Holz B, Haedicke J, von Wasielewski R, Martus P, Iftner T.

BMC Infect Dis. 2014 Dec 9;14:674. doi: 10.1186/s12879-014-0674-1.

36.

Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.

Thomsen LT, Frederiksen K, Munk C, Junge J, Iftner T, Kjaer SK.

Int J Cancer. 2015 Jul 1;137(1):193-203. doi: 10.1002/ijc.29374. Epub 2014 Dec 12.

37.
38.

A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion.

Mauz PS, Zago M, Kurth R, Pawlita M, Holderried M, Thiericke J, Iftner A, Stubenrauch F, Sotlar K, Iftner T.

Virol J. 2014 Jun 18;11:114. doi: 10.1186/1743-422X-11-114.

39.

Detection of mutation-specific epidermal growth factor receptor (E746-A750del) and lack of detection of human papillomavirus in oral squamous cell carcinoma.

Grimm M, Iftner T, Altaki H, Iftner A, Peters JP, Munz A, Reinert S.

Int J Oral Maxillofac Surg. 2014 Oct;43(10):1199-205. doi: 10.1016/j.ijom.2014.04.006. Epub 2014 May 10.

PMID:
24818747
40.

Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.

Jensen KE, Thomsen LT, Schmiedel S, Frederiksen K, Norrild B, van den Brule A, Iftner T, Kjær SK.

Sex Transm Infect. 2014 Nov;90(7):550-5. doi: 10.1136/sextrans-2013-051431. Epub 2014 Apr 12.

PMID:
24728044
41.

Evaluation of positron emission tomographic tracers for imaging of papillomavirus-induced tumors in rabbits.

Probst S, Wiehr S, Mantlik F, Schmidt H, Kolb A, Münch P, Delcuratolo M, Stubenrauch F, Pichler BJ, Iftner T.

Mol Imaging. 2014;13. doi: 10.2310/7290.2013.00070.

PMID:
24622808
42.

Detection of oncogenic genital human papillomavirus (HPV) among HPV negative older and younger women after 7 years of follow-up.

Brogaard KA, Munk C, Iftner T, Frederiksen K, Kjaer SK.

J Med Virol. 2014 Jun;86(6):975-82. doi: 10.1002/jmv.23914. Epub 2014 Mar 7.

PMID:
24610211
43.

High-risk and low-risk human papillomavirus and the absolute risk of cervical intraepithelial neoplasia or cancer.

Thomsen LT, Frederiksen K, Munk C, Junge J, Castle PE, Iftner T, Kjaer SK.

Obstet Gynecol. 2014 Jan;123(1):57-64. doi: 10.1097/AOG.0000000000000056.

PMID:
24463664
44.

Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.

Dartell MA, Rasch V, Iftner T, Kahesa C, Mwaiselage JD, Junge J, Gernow A, Ejlersen SF, Munk C, Kjaer SK.

Int J Cancer. 2014 Aug 15;135(4):896-904. doi: 10.1002/ijc.28712. Epub 2014 Feb 4.

45.

Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?

Kjær SK, Munk C, Junge J, Iftner T.

Cancer Causes Control. 2014 Feb;25(2):179-89. doi: 10.1007/s10552-013-0320-z. Epub 2013 Nov 17.

PMID:
24242002
46.

The viral E8^E2C repressor limits productive replication of human papillomavirus 16.

Straub E, Dreer M, Fertey J, Iftner T, Stubenrauch F.

J Virol. 2014 Jan;88(2):937-47. doi: 10.1128/JVI.02296-13. Epub 2013 Nov 6.

47.

Persistence and reappearance of high-risk human papillomavirus after conization.

Gosvig CF, Huusom LD, Andersen KK, Iftner A, Cederkvist L, Svare E, Iftner T, Kjaer SK.

Gynecol Oncol. 2013 Dec;131(3):661-6. doi: 10.1016/j.ygyno.2013.09.002. Epub 2013 Sep 13.

PMID:
24035849
48.

The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening.

Heideman DA, Hesselink AT, van Kemenade FJ, Iftner T, Berkhof J, Topal F, Agard D, Meijer CJ, Snijders PJ.

J Clin Microbiol. 2013 Nov;51(11):3653-7. doi: 10.1128/JCM.01517-13. Epub 2013 Aug 28.

49.

Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status.

Olesen TB, Iftner T, Mwaiselage J, Kahesa C, Rasch V, Ngoma T, Munk C, Kjaer SK.

Sex Transm Dis. 2013 Jul;40(7):592-8. doi: 10.1097/OLQ.0b013e31828fcf57.

PMID:
23965778
50.

Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.

Dartell M, Rasch V, Munk C, Kahesa C, Mwaiselage J, Iftner T, Kjaer SK.

Sex Transm Dis. 2013 Sep;40(9):737-43. doi: 10.1097/OLQ.0000000000000005.

PMID:
23949589

Supplemental Content

Loading ...
Support Center